JP2008509999A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008509999A5 JP2008509999A5 JP2007527837A JP2007527837A JP2008509999A5 JP 2008509999 A5 JP2008509999 A5 JP 2008509999A5 JP 2007527837 A JP2007527837 A JP 2007527837A JP 2007527837 A JP2007527837 A JP 2007527837A JP 2008509999 A5 JP2008509999 A5 JP 2008509999A5
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- group
- hydroxy
- silyloxy
- acyloxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 31
- 239000001257 hydrogen Substances 0.000 claims 31
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 25
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 17
- 125000004423 acyloxy group Chemical group 0.000 claims 14
- 125000003545 alkoxy group Chemical group 0.000 claims 13
- 150000001875 compounds Chemical class 0.000 claims 13
- -1 methoxymethoxy Chemical group 0.000 claims 10
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 9
- 125000002757 morpholinyl group Chemical group 0.000 claims 8
- 229910052757 nitrogen Inorganic materials 0.000 claims 8
- 125000003386 piperidinyl group Chemical group 0.000 claims 8
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical group 0.000 claims 4
- 150000002431 hydrogen Chemical group 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000035475 disorder Diseases 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 102000015694 estrogen receptors Human genes 0.000 claims 3
- 108010038795 estrogen receptors Proteins 0.000 claims 3
- 206010020718 hyperplasia Diseases 0.000 claims 3
- 230000001404 mediated effect Effects 0.000 claims 3
- 201000009273 Endometriosis Diseases 0.000 claims 2
- 208000033830 Hot Flashes Diseases 0.000 claims 2
- 206010060800 Hot flush Diseases 0.000 claims 2
- 208000001132 Osteoporosis Diseases 0.000 claims 2
- 206010047791 Vulvovaginal dryness Diseases 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 239000000583 progesterone congener Substances 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- BRSSNUNHNSVDIS-UHFFFAOYSA-N 3-(4-hydroxyphenyl)-5-[[3-(2-piperidin-1-ylethoxy)phenyl]methyl]-3,4-dihydro-2h-1,5-benzoxazepin-8-ol Chemical compound C1=CC(O)=CC=C1C1CN(CC=2C=C(OCCN3CCCCC3)C=CC=2)C2=CC=C(O)C=C2OC1 BRSSNUNHNSVDIS-UHFFFAOYSA-N 0.000 claims 1
- 206010065687 Bone loss Diseases 0.000 claims 1
- 208000014644 Brain disease Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010008342 Cervix carcinoma Diseases 0.000 claims 1
- 206010014733 Endometrial cancer Diseases 0.000 claims 1
- 206010014759 Endometrial neoplasm Diseases 0.000 claims 1
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims 1
- 206010046798 Uterine leiomyoma Diseases 0.000 claims 1
- GHGIGALAGKPBOH-UHFFFAOYSA-N [8-hydroxy-3-(3-hydroxyphenyl)-3,4-dihydro-2h-1,5-benzoxazepin-5-yl]-[3-(2-piperidin-1-ylethoxy)phenyl]methanone Chemical compound OC1=CC=CC(C2CN(C3=CC=C(O)C=C3OC2)C(=O)C=2C=C(OCCN3CCCCC3)C=CC=2)=C1 GHGIGALAGKPBOH-UHFFFAOYSA-N 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 210000000481 breast Anatomy 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 208000026106 cerebrovascular disease Diseases 0.000 claims 1
- 201000010881 cervical cancer Diseases 0.000 claims 1
- 210000000038 chest Anatomy 0.000 claims 1
- 230000003920 cognitive function Effects 0.000 claims 1
- 238000002648 combination therapy Methods 0.000 claims 1
- 239000003433 contraceptive agent Substances 0.000 claims 1
- 230000002254 contraceptive effect Effects 0.000 claims 1
- 230000003412 degenerative effect Effects 0.000 claims 1
- 201000006828 endometrial hyperplasia Diseases 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- 201000010260 leiomyoma Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60205404P | 2004-08-17 | 2004-08-17 | |
| PCT/US2005/026944 WO2006023242A1 (en) | 2004-08-17 | 2005-07-28 | Benzoxazepine derivatives as selective estrogen receptor modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008509999A JP2008509999A (ja) | 2008-04-03 |
| JP2008509999A5 true JP2008509999A5 (cg-RX-API-DMAC7.html) | 2008-09-04 |
Family
ID=35431802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007527837A Withdrawn JP2008509999A (ja) | 2004-08-17 | 2005-07-28 | 選択的なエストロゲン受容体モジュレーターとしてのベンズオキサゼピン誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060040917A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1778656A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008509999A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101039925A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2576747A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006023242A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2619214B1 (en) * | 2010-09-20 | 2014-12-24 | Novartis AG | Novel process for the preparation of 9-deoxo-9a-aza-9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group |
| KR101363472B1 (ko) | 2011-03-30 | 2014-02-17 | 한국화학연구원 | 신규한 크로멘 유도체, 이의 약학적으로 허용가능한 염 또는 이의 이성질체, 이의 제조방법 및 이를 포함하는 ｐａｒ-1 관련 질환의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5552412A (en) * | 1995-01-09 | 1996-09-03 | Pfizer Inc | 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis |
| DE19833786A1 (de) * | 1998-07-18 | 2000-01-20 | Schering Ag | Benzocycloheptene, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| WO2002094788A1 (en) * | 2001-05-22 | 2002-11-28 | Eli Lilly And Company | 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
-
2005
- 2005-07-28 CN CNA2005800351717A patent/CN101039925A/zh active Pending
- 2005-07-28 US US11/191,499 patent/US20060040917A1/en not_active Abandoned
- 2005-07-28 JP JP2007527837A patent/JP2008509999A/ja not_active Withdrawn
- 2005-07-28 EP EP05767648A patent/EP1778656A1/en not_active Withdrawn
- 2005-07-28 WO PCT/US2005/026944 patent/WO2006023242A1/en not_active Ceased
- 2005-07-28 CA CA002576747A patent/CA2576747A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2280766T3 (es) | 5-(2-hidroxi-3'-1-(3-trifluorometilfenil)-ciclopropil)-propionilamino)-ftalida y compuestos afines con actividad moduladora del receptor de progesterona, para uso en control de la fertilidad y terapia de reemplazamiento hormonal. | |
| RU2007101303A (ru) | Модуляторы рецепторов прогестерона, содержащие производные пиррол-оксиндола и их применение | |
| KR20150119385A (ko) | 선택적 에스트로겐 수용체 분해제로서의 벤조티오펜 유도체 및 그의 조성물 | |
| HRP20100366T1 (hr) | Antagonisti receptora progesterona | |
| JP2019510799A (ja) | テトラヒドロイソキノリン エストロゲン受容体モジュレーター及びその使用 | |
| CN117462688A (zh) | 一种包含kras g12d抑制剂的组合物 | |
| KR20230121756A (ko) | Fgfr 억제제 및 이의 제조 및 사용 방법 | |
| ES2919572T3 (es) | Compuestos antiproliferación y usos de los mismos | |
| CN102753565A (zh) | 孕酮受体拮抗剂 | |
| US6319912B1 (en) | Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides | |
| JP2014530243A (ja) | Ａｒｒｙ−３８０の多形体、選択的ｈｅｒｂ２阻害剤、およびそれらを含有する薬学的組成物 | |
| EP1896034B8 (en) | Micronized tanaproget compositions and methods of preparing the same | |
| JP2008509999A5 (cg-RX-API-DMAC7.html) | ||
| JP2006511498A5 (cg-RX-API-DMAC7.html) | ||
| RU2004118606A (ru) | Тетрациклические гетеросоединения в качестве модуляторов эстрогенных рецепторов | |
| DE60105785D1 (de) | Halogenierte triphenylethylene derivate als selektive östrogenrezeptormodulatoren | |
| RU2010100331A (ru) | ПРОИЗВОДНОЕ 17β-ЦИАНО-19-НОР-АНДРОСТ-4-ЕНА, ЕГО ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННЫЕ СРЕДСТВА, СОДЕРЖАЩИЕ УКАЗАННОЕ ПРОИЗВОДНОЕ | |
| PL1874278T3 (pl) | Kompozycje zawierające mikronizowany tanaproget | |
| EA201100226A1 (ru) | Производные эстратриена, содержащие гетероциклические биоизостеры для фенольного а-кольца | |
| JP4347420B2 (ja) | 新規な４−ハロゲン化ステロイド、それらの製造方法及び中間体、それらの薬剤としての用途並びに及びそれらを含有する製薬組成物 | |
| CN105120873A (zh) | 孕酮受体拮抗剂剂型 | |
| JP2008520688A5 (cg-RX-API-DMAC7.html) | ||
| RU2010100337A (ru) | ПРОИЗВОДНОЕ 17β-ЦИАНО-19-АНДРОСТ-4-ЕНА, ЕГО ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННЫЕ СРЕДСТВА, КОТОРЫЕ ВКЛЮЧАЮТ ПРОИЗВОДНОЕ | |
| CN101863903B (zh) | 1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用 | |
| US6423700B1 (en) | 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |